UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 344

Sortiert nach

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

The lancet oncology, 2020-03, Vol.21 (3), p.398-411

2020

Volltextzugriff (PDF)

Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

The lancet oncology, 2014-05, Vol.15 (6), p.631-639

2014

Volltextzugriff (PDF)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

The Lancet (British edition), 2011-05, Vol.377 (9779), p.1749-1759

2011

Volltextzugriff (PDF)

D14 Experience with losartan in 3 categories of hypertensive patients

American journal of hypertension, 1997-04, Vol.10 (S2), p.108A-108A

1997

Volltextzugriff (PDF)

Bringing function to the forefront of cell therapy: how do we demonstrate potency?

Frontiers in immunology, 2023-07, Vol.14, p.1226841-1226841

2023

Volltextzugriff (PDF)

Tissue‐Engineered Tracheal Replacement in a Child: A 4‐Year Follow‐Up Study

American journal of transplantation, 2015-10, Vol.15 (10), p.2750-2757

2015

Volltextzugriff (PDF)

Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures

PloS one, 2019-06, Vol.14 (6), p.e0218674-e0218674

2019

Volltextzugriff (PDF)

Biochemical changes caused by decellularization may compromise mechanical integrity of tracheal scaffolds

Acta biomaterialia, 2013-02, Vol.9 (2), p.5251-5261

2013

Volltextzugriff (PDF)

Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer

Stem cells translational medicine, 2020-09, Vol.9 (9), p.974-984

2020

Volltextzugriff (PDF)

Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial

PloS one, 2015-06, Vol.10 (6), p.e0123416-e0123416

2015

Volltextzugriff (PDF)

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study

The Lancet (British edition), 2012-09, Vol.380 (9846), p.994-1000

2012

Volltextzugriff (PDF)

Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model

Proceedings of the National Academy of Sciences - PNAS, 2013-08, Vol.110 (35), p.14360-14365

2013

Volltextzugriff (PDF)

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

Clinical infectious diseases, 2011-01, Vol.52 (1), p.49-57

2011

Volltextzugriff (PDF)

Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds

Biomaterials, 2017-04, Vol.124, p.95-105

2017

Volltextzugriff (PDF)

Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy

Scientific reports, 2024-05, Vol.14 (1), p.11421-11421, Article 11421

2024

Volltextzugriff (PDF)

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

The Journal of experimental medicine, 2008-08, Vol.205 (8), p.1869-1877

2008

Volltextzugriff (PDF)

Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents

Nanoscale, 2016-02, Vol.8 (6), p.3278-3287

2016

Volltextzugriff (PDF)

Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?

Regenerative medicine, 2020-03, Vol.15 (3), p.1463-1491

2020

Volltextzugriff (PDF)

Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging

Scientific reports, 2017-08, Vol.7 (1), p.7850-14, Article 7850

2017

Volltextzugriff (PDF)

The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products

British journal of haematology, 2017-01, Vol.176 (1), p.9-15

2017

Volltextzugriff (PDF)

Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2021-10, Vol.39 (30), p.3352-3363

2021

Volltextzugriff (PDF)

Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells

Cytotherapy (Oxford, England), 2012-10, Vol.14 (9), p.1110-1118

2012

Volltextzugriff (PDF)

Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis

Cancers, 2024-03, Vol.16 (6), p.1186

2024

Volltextzugriff (PDF)

Manufacturing chimeric antigen receptor T cells: issues and challenges

Cytotherapy (Oxford, England), 2019-03, Vol.21 (3), p.327-340

2019

Volltextzugriff (PDF)

GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering

Scientific reports, 2021-06, Vol.11 (1), p.12392-12392, Article 12392

2021

Volltextzugriff (PDF)

1 – 25 von 344

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(311)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(343)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cytotherapy
(39)
Blood
(29)
The Lancet
(13)
Bone Marrow Transplantation
(10)
Plos One
(9)
Transfusion Medicine
(7)
British Journal Of Haematology
(6)
Clinical Oncology
(6)
Biology Of Blood And Marrow Transplantation
(5)
Clinical And Experimental Immunology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

D14 Experience with losartan in 3 categories of hypertensive patients

Bringing function to the forefront of cell therapy: how do we demonstrate potency?

Tissue‐Engineered Tracheal Replacement in a Child: A 4‐Year Follow‐Up Study

Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures

Biochemical changes caused by decellularization may compromise mechanical integrity of tracheal scaffolds

Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer

Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study

Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds

Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents

Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?

Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging

The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products

Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells

Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis

Manufacturing chimeric antigen receptor T cells: issues and challenges

GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering

Suchergebnisse filtern